메뉴 건너뛰기




Volumn 14, Issue 22, 2007, Pages 2330-2334

Noradrenaline in Parkinson's disease: From disease progression to current therapeutics

Author keywords

Alpha receptors; D1 receptors; DA agonists; Dyskinesia; L DOPA; Locus coeruleus; Neurodegeneration

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIHYDROERGOCRYPTINE; DIZOCILPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; EFAROXAN; GLUTAMATE RECEPTOR; IDAZOXAN; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NORADRENALIN; PHOSPHOPROTEIN DARPP 32; REBOXETINE; THREO 3,4 DIHYDROXYPHENYLSERINE; ZOTEPINE;

EID: 35448979969     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986707781745550     Document Type: Review
Times cited : (91)

References (88)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.